Palbociclib (Standard)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Palbociclib (Standard)
Description:
Palbociclib (Standard) is the analytical standard of Palbociclib. This product is intended for research and analytical applications. Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4].Product Name Alternative:
PD 0332991 (Standard)UNSPSC:
12352005Hazard Statement:
H341, H361, H373, H411Target:
CDK; Reference StandardsType:
Reference StandardsRelated Pathways:
Cell Cycle/DNA Damage; OthersApplications:
Cancer-Kinase/proteaseField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/palbociclib-standard.htmlPurity:
99.23Smiles:
O=C1C (C (C) =O) =C (C2=CN=C (N=C2N1C3CCCC3) NC4=CC=C (N5CCNCC5) C=N4) CMolecular Formula:
C24H29N7O2Molecular Weight:
447.53Precautions:
H341, H361, H373, H411References & Citations:
[1]Fry DW, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther. 2004 Nov;3 (11) :1427-38. |[2]Goel S, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature. 2017 Aug 24;548 (7668) :471-475. |[3]Richard S Finn, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 2009;11 (5) :R77. |[4]Bollard J, et al. Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut. 2017 Jul;66 (7) :1286-1296.Shipping Conditions:
Blue IceStorage Conditions:
4°C, sealed storage, away from light and moistureScientific Category:
Reference StandardsCAS Number:
571190-30-2
